Key statistics
On Friday, Phathom Pharmaceuticals Inc (PHAT:NSQ) closed at 18.43, -6.49% below its 52-week high of 19.71, set on Sep 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 18.68 |
---|---|
High | 19.00 |
Low | 17.97 |
Bid | 18.39 |
Offer | 19.00 |
Previous close | 18.72 |
Average volume | 1.35m |
---|---|
Shares outstanding | 59.59m |
Free float | 53.91m |
P/E (TTM) | -- |
Market cap | 1.10bn USD |
EPS (TTM) | -5.13 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
- Phathom Pharmaceuticals Announces Pricing of $130 Million Offering of Common Stock and Pre-Funded Warrants
- Phathom Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
- Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Added to CVS Caremark Formularies for Commercially Insured Patients
- Phathom Pharmaceuticals to Report Second Quarter 2024 Financial Results and Provide Business Update on Thursday, August 8, 2024
- Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA® (vonoprazan) Tablets for the Relief of Heartburn Associated with Non-Erosive GERD in Adults
- Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2024 Annual Meeting
- Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
- Phathom Pharmaceuticals to Report First Quarter 2024 Financial Results and Provide Business Update on Thursday, May 9, 2024
- Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
More ▼